U.S. Food Stock News

Arthur J. Gallagher & Co. recently reported its second quarter 2025 results, with revenue rising to US$3.22 billion and net income reaching US$365.8 million, both up from the same period last year; the company also reaffirmed its regular quarterly cash dividend. Despite having an existing share repurchase authorization, Arthur J. Gallagher did not buy back any shares in the latest reported period, highlighting a focus on reinvestment and capital returns via dividends instead of...

ArcBest Corporation recently reported results for the second quarter and first half of 2025, showing year-over-year declines in sales to US$1,022.26 million and net income to US$25.81 million for the quarter, alongside completion of a share buyback covering nearly 27% of total shares since 2003. This demonstrates how operational and profitability pressures have persisted, even as the company continued to repurchase shares in support of shareholder value. We'll explore how ArcBest’s softer...

Atkore Inc. recently reported third quarter results, revealing a decline in sales to US$735.05 million and net income to US$42.96 million, alongside an announcement that CEO and President William (Bill) Waltz will retire once a successor is named. The combination of a sharp decrease in earnings and an upcoming leadership change could prompt questions about Atkore's current business momentum and future direction. We'll examine how the significant earnings shortfall impacts Atkore's investment...

Wave Life Sciences Ltd. recently reported its second quarter 2025 results, disclosing sales of US$8.7 million and a net loss of US$50.47 million, both adversely affected compared to the same period last year. The company’s basic loss per share from continuing operations increased to US$0.31, reflecting growing expenses and a less robust revenue stream during the period. We'll examine how the sharp year-over-year drop in quarterly sales may alter Wave Life Sciences' investment narrative and...

Earlier this month, Rheinmetall Landsysteme Germany announced Curtiss-Wright will supply modular turret drive stabilization systems for the KF51 Panther Main Battle Tank, and Curtiss-Wright also expanded its 2025 share repurchase program by US$200 million, bringing expected annual buybacks to US$266 million. This combination of a significant new defense technology contract and a stepped-up capital return program highlights Curtiss-Wright’s focus on growth and shareholder returns through...

Sweetgreen, Inc. recently reported second-quarter 2025 results, with sales of US$185.58 million and a net loss of US$23.16 million, alongside updated full-year guidance forecasting revenue between US$700 million and US$715 million and a same-store sales decline of 6% to 4%. While Sweetgreen expects at least 40 new restaurant openings in 2025, including 20 Infinite Kitchen locations, its guidance highlights pressure on same-store sales growth and profitability. To assess how Sweetgreen’s...

In the past week, Polestar Automotive Holding UK reported second-quarter 2025 delivery results of 18,049 vehicles, surpassing analyst expectations and marking an increase from 13,072 deliveries in Q2 2024. This operational milestone was accompanied by a cautious company outlook, as Polestar paused 2025 financial guidance amid challenging macroeconomic conditions, tariff uncertainties, and ongoing profitability concerns. We'll now consider how Polestar's delivery outperformance and paused...

Lemonade, Inc. announced its second quarter 2025 earnings, reporting revenue of US$164.1 million and a reduced net loss of US$43.9 million compared to the same period last year. Improved financial results and persistent institutional investor interest highlight Lemonade's ongoing efforts to enhance operational efficiency and expand its market position through technology. We'll explore how Lemonade's narrowing net losses and substantial revenue growth impact the company's broader investment...

Novasign announced in late July 2025 that it has entered into a partnership with Repligen Corporation to integrate its machine learning and modeling workflow into Repligen's tangential flow filtration (TFF) systems, with Repligen also investing in Novasign to support its growth. This collaboration introduces advanced analytics capabilities to Repligen's filtration systems, enabling more efficient process development and potentially addressing critical industry needs for faster, lower-risk,...

In recent weeks, Vertiv Holdings Co reported strong second quarter results, raised its full-year outlook, and unveiled Vertiv OneCore, a turnkey, scalable prefabricated data center infrastructure now available globally and targeted at high-density, AI-focused deployments. This convergence of robust financial performance and the launch of an innovative, integrated solution highlights Vertiv’s ability to address rapidly evolving data center demands worldwide. We'll examine how the Vertiv...

Perella Weinberg Partners has announced a strong earnings turnaround for the second quarter of 2025, completed additional share buybacks, appointed new independent directors, and reaffirmed its quarterly dividend of US$0.07 per share. This combination of improved profitability and multiple shareholder-focused actions highlights the firm's efforts to strengthen its governance, capital allocation, and operational performance. We'll explore how Perella Weinberg's swing to profitability and...

ARMOUR Residential REIT, Inc. recently completed a follow-on equity offering of 18,500,000 common shares, raising approximately US$302.48 million after amending its authorized share count from 125,000,000 to 175,000,000 shares. This sequence of actions expands the company's financial flexibility and alters its future capital structure and potential growth trajectory. We'll explore how ARMOUR Residential REIT's expanded authorized shares and completed equity offering shape its overall...

Pulse Biosciences recently reported a net loss of US$19.17 million for the second quarter ended June 30, 2025, alongside updates on its nsPFA technology programs and regulatory progress. The company is advancing key clinical milestones, including expanding its pilot program for soft tissue ablation and preparing for pivotal trials in atrial fibrillation and benign thyroid disease. We'll examine how the expanded pilot program for the nsPFA Percutaneous Electrode influences Pulse Biosciences’...

Azenta, Inc. reported its third quarter fiscal 2025 results, showing revenue of US$143.94 million and a net loss of US$52.81 million, alongside a reaffirmed guidance for 3% to 5% organic revenue growth for the year. Additionally, Azenta announced a new collaboration with Frenova and Nephronomics to provide genomic sequencing for a major genomics research program focused on cardio-kidney-metabolic diseases. We’ll now explore how Azenta’s reaffirmed growth outlook could influence its...

Regal Rexnord reported second quarter results that met revenue expectations and delivered stronger year-over-year earnings, updated its 2025 earnings guidance, and announced a new partnership with ABB Robotics to advance its automation offerings, while also confirming a key executive transition set for the end of the year. The collaboration with ABB Robotics, enabling Regal Rexnord’s Thomson Movotrak CTU to become the first certified 7th axis technology for ABB cobots, highlights the...

Genworth Financial reported second quarter 2025 results, noting net income of US$51 million, a decrease from US$76 million in the prior year's quarter, and announced that it completed repurchasing over 108 million shares for US$629.96 million since launching its buyback in May 2022. This substantial buyback represents nearly a quarter of outstanding shares, highlighting the company's commitment to returning capital to shareholders during a period of lower net earnings. We'll examine how...

Earlier this month, ACI Worldwide reported second quarter 2025 results with revenue of US$401.26 million, exceeding analyst expectations, and raised its full-year 2025 revenue guidance to a range of US$1.71 billion to US$1.74 billion following strong year-to-date growth. Alongside robust financials, ACI Worldwide completed a significant share repurchase, retired millions of shares, and advanced its next-generation payments platform to capitalize on digital payments trends and regulatory...

On August 7, 2025, UWM Holdings Corporation announced its second quarter results, reporting revenue of US$758.7 million and net income of US$22.91 million, both higher than the prior year, along with third quarter guidance of production between US$33 billion and US$40 billion and a gain margin of 100 to 125 basis points; the company also affirmed a US$0.10 per share cash dividend for October 2025. The combination of stronger year-over-year earnings, forward-looking operational guidance, and...

During the second quarter of 2025, Avis Budget Group completed its long-standing share repurchase program, buying back a total of 83,626,152 shares for US$7.36 billion, although no shares were repurchased between April and June 2025. Meanwhile, Avis continued to contend with operational headwinds such as vehicle recalls and delivery delays, while also expanding premium services with the rollout of Avis First and deepening its partnership with Waymo in autonomous vehicle fleet...

In the past week, IPG Photonics Corporation completed a share buyback program totaling 3,600,367 shares for US$279.93 million and reported second-quarter 2025 earnings, highlighting year-over-year declines in both revenue and net income. Alongside these updates, new leadership appointments were announced to strengthen human resources, global laser systems, and component management, signaling a renewed focus on advancing growth, innovation, and operational capability across the company. We'll...

Janux Therapeutics recently announced the dosing of the first patient in its TRACTr collaboration program with Merck, triggering a US$10 million milestone payment and highlighting clinical progress across its pipeline, including Phase 1 trials for JANX007 and JANX008. This milestone underscores the continued momentum in Janux’s innovative bispecific product pipeline for oncology and potential therapies for autoimmune diseases. We'll explore how clinical progress and milestone payments from...

Astec Industries announced its second quarter 2025 results, reporting US$330.3 million in sales and a swing to net income of US$16.7 million from a net loss in the prior year, alongside a new shelf registration for over US$52.8 million in common stock. Despite a year-over-year drop in quarterly sales, the company's turnaround to profitability suggests improved cost control or operational efficiency played a crucial role this period. We’ll examine how Astec Industries’ return to profit after...

In July 2025, EMCOR Group reported strong earnings for the second quarter and first half, with sales rising to US$4.30 billion and US$8.17 billion respectively, alongside increased net income and earnings per share compared to the prior year. The company also raised its full-year 2025 revenue guidance and completed substantial share repurchases, signaling management's confidence in ongoing business momentum and operational performance. We'll explore how EMCOR Group’s raised revenue outlook...

In recent days, ABM Industries has seen elevated options market activity, with high implied volatility for the October 17, 2025 $22.50 call, as well as analysts slightly raising earnings estimates and maintaining a positive outlook. This combination of heightened options activity and improved analyst sentiment suggests that investors anticipate a significant move or event affecting the company’s prospects. We'll consider how the increased options volatility and positive analyst revisions...